SC
INSM icon

Stephens Consulting’s Insmed INSM Stock Holding History

Stephens Consulting’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10
Closed -$1.01K – 766
2025
Q2 		$1.01K Sell
10
-40
-80% -$3.06K ﹤0.01% 665
2025
Q1 		$3.81K Buy
+50
New +$3.83K ﹤0.01% 398
2024
Q3 		– Sell
-70
Closed -$4.69K – 583
2024
Q2 		$4.69K Buy
+70
New +$2.71K ﹤0.01% 417

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Stephens Consulting's INSM Position: Q3 2025 in Review

Stephens Consulting sold out of Insmed (INSM) in Q3 2025, closing a stake of 10 shares — an estimated $1.01K sold.

Stephens Consulting first reported a position in INSM in Q2 2024 and held it in 3 quarters. The position peaked at $4.69K in Q2 2024. 566 funds tracked by Wall St. Rank hold INSM as of Q3 2025.

  • Stephens Consulting reported no remaining Insmed position as of Q3 2025 after selling out during the quarter.
  • Stephens Consulting sold 10 Insmed shares in Q3 2025, an estimated $1.01K.
  • Stephens Consulting first reported a position in Insmed in Q2 2024 and held it in 3 quarters.
  • Stephens Consulting's Insmed position peaked at $4.69K in Q2 2024.
  • 566 funds tracked by Wall St. Rank held Insmed as of Q3 2025.

Based on Stephens Consulting's 13F filing for Q3 2025, filed 15 Oct 2025.